BioNTech SE (BNTX) Divestments (2019 - 2025)

BioNTech SE's (BNTX) quarterly Divestments came in at -$1.1 billion in Q3 2025, down 593.16% year-on-year from $219.3 million in Q3 2024, and down 1383.89% quarter-over-quarter from -$72.9 million in Q2 2025.

BioNTech SE (BNTX) Divestments (2019 - 2025) Analysis & Trends

BioNTech SE has disclosed Divestments across 7 years of filings, most recently posting -$1.1 billion for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 BioNTech SE 27.38 Bn 10.07 Bn 668.28 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.08 Bn
Jun 30, 2025 -72.90 Mn
Mar 31, 2025 1.31 Bn
Sep 30, 2024 -156.06 Mn
Jun 30, 2024 -259.96 Mn
Mar 31, 2024 -2.50 Bn
Sep 30, 2023 -1.34 Bn
Jun 30, 2023 -2.50 Bn
Mar 31, 2023 -789.34 Mn
Sep 30, 2022 -83.99 Mn
Jun 30, 2022 -83.66 Mn
Mar 31, 2022 322.56 Mn
Sep 30, 2021 549.78 Mn
Jun 30, 2021 35.89 Mn
Mar 31, 2021 34.14
Sep 30, 2020 487.56 Mn
Jun 30, 2020 -10.79 Mn
Mar 31, 2020 -16.49 Mn
Sep 30, 2019 -215.40 Mn
Jun 30, 2019 70.91 Mn